Serum hyaluronan levels in patients with knee osteoarthritis

Clinical Rheumatology

Volumn 26, Issue 8, 2007, Pages 1293-1298

  Turan, Yasemin ^a,b   Bal, Serpil ^a   Gurgan, Alev ^a   Topac, Hatice ^a   Koseoglu, Mehmet ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Disease activity; Hyaluronic acid; Osteoarthritis

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; HYALURONIC ACID;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISABILITY SEVERITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE;

EID: 34447121273     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0499-4     Document Type: Article

References (29)

1. Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, Dragomir AD, Helmick CG, Hochberg MC, Jordan JM (2005) Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 52:105-111
2. Sharif M, George E, Shepstone L, Knudson W, Thonar EJ, Cushnaghan J, Dieppe P (1995) Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 38:760-767
3. Garnero P, Rousseau JC, Delmas PD (2000) Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43:953-968
4. Wells AF, Klareskog L, Lindblad S, Laurent TC (1992) Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: A role for macrophage-derived factors. Arthritis Rheum 35:391-396
5. Laurent TC, Dahl IM, Dahl LB, Engstrom-Laurent A, Eriksson S, Fraser JR, Granath KA, Laurent C, Laurent UB, Lilja K et al (1986) The catabolic fate of hyaluronic acid. Connect Tissue Res 15:33-41
6. Hallgren R, Engstrom-Laurent A, Nisbeth U (1987) Circulating hyaluronate: A potential marker of altered metabolism of the connective tissue in uremia. Nephron 46:150-154
7. Wilkinson CR, Bower LM, Warren C (1996) The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta 256:165-173
8. Manley G, Warren C (1987) Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 1987 40:626-630
9. Faber J, Horslev-Petersen K, Perrild H, Lorenzen I (1990) Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid. J Clin Endocrinol Metab 71:1016-1021
10. Ozasa H, Chichibu K, Tanaka Y, Kondo T, Kitajima K, Ota K (1992) Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients. Nephron 61:187-191
11. Engstrom-Laurent A, Hallgren R (1985) Circulating hyaluronate in rheumatoid arthritis: Relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 44:83-88
12. Lundin A, Engstrom-Laurent A, Hallgren R, Michaelsson G (1985) Circulating hyaluronate in psoriasis. Br J Dermatol 112:663-671
13. Nishida Y, D'Souza AL, Thonar EJM, Knudson W (2000) Stimulation of hyaluronan metabolism by interleukin 1α in human articular cartilage. Arthritis Rheum 43:1315-1326
14. Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18(Suppl 27):19-23
15. Kellgren JH, Lawrence JS (eds) (1963) The epidemiology of chronic rheumatism, atlas of standard radiographs. Blackwell, Oxford, UK
16. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L (1988) Validation study of WOMAC: A health status instrument for measuring clinically-important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol 1:95-108
17. Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH (2003) A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 278:9808-9812
18. Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M (1990) Inflammation and cartilage metabolism in rheumatoid arthritis: studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 33:790-799
19. Manicourt DH, Triki R, Fukuda K, Devogelaer JP, de Deuxchasnes CN, Thonar EJ (1993) Levels of circulating tumor necrosis factor and interleukin-6 in patients with rheumatoid arthritis: Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 36:490-499
20. Hedin PJ, Weitoft T, Hedin H, Engstrom-Laurent A, Saxne T (1991) Serum concentrations of hyaluronan and proteoglycan in joint disease: Lack of association. J Rheumatol 18:1601-1605
21. Emlen W, Niebur J, Flanders G, Rutledge J (1996) Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: Correlation with disease activity. J Rheumatol 23:974-978
22. Sharma L, Hurwitz DE, Thonar EJ, Sum JA, Lenz ME, Dunlop DD, Schnitzer TJ, Kirwan-Mellis G, Andriacchi TP (1998) Knee adduction moment, serum hyaluronan level, and disease severity in medial tibiofemoral osteoarthritis. Arthritis Rheum 41(7):1233-1240
23. Thonar EJ, Masuda K, Lenz ME, Hauselmann HJ, Kuettner KE, Manicourt DH (1995) Serum markers of systemic disease processes in osteoarthritis. J Rheumatol Suppl 43:68-70
24. Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ (1991) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34:799-807
25. Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L (2002) C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthr Cartil 10:595-601
26. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB (1997) Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 40:723-727
27. Horslev-Petersen K, Bentsen KD, Engström-Laurent A, Junker P, Halberg P, Lorenzen I (1988) Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: Relation to clinical and serological parameters of inflammation during 8 and 24 months treatment with levamisole, penicillamine, or azothioprine. Ann Rheum Dis 47:116-126
28. Levesque H, Delpech B, Le Loet X, Deshayes P (1988) Serum hyaluronate in rheumatoid arthritis: Study by affino-immunoenzymatic assay. Br J Rheumatol 27:445-449
29. Di Cesare PE, Abramson SB (2005) Pathogenesis of osteoarthritis. In: Harris ED (ed) Kelley's textbook of rheumatology, 7th edn. Elsevier, Philadelphia, PA, pp 1493-1513